Chehalis, WA, United States of America

Katheryne Wilson

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The University of Texas System. Active years: 2014.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Katheryne Wilson: Innovator in Nanocarrier Technology

Introduction

Katheryne Wilson is a prominent inventor based in Chehalis, WA (US). She has made significant contributions to the field of nanotechnology, particularly in the development of nanocarriers for imaging and therapy applications. Her innovative work has the potential to enhance medical treatments and diagnostic techniques.

Latest Patents

Katheryne Wilson holds 1 patent for her invention titled "Nanocarriers for imaging and therapy applications." This patent presents nanocarriers and methods of preparation and use. In some embodiments, her nanocarrier composition comprises an organic liquid containing a plurality of nanoparticles dispersed within it, along with a coating material surrounding the exterior surface of the organic liquid. This technology allows for biological tissue to be imaged or treated by coming into contact with the nanocarrier composition, which can be irradiated in certain applications.

Career Highlights

Katheryne Wilson is affiliated with the University of Texas System, where she continues to advance her research in nanotechnology. Her work is recognized for its potential impact on medical imaging and therapeutic applications, showcasing her dedication to innovation in the field.

Collaborations

Some of her notable coworkers include Kimberly A Homan and Stanislav Emelianov, who contribute to her research endeavors and collaborative projects.

Conclusion

Katheryne Wilson's contributions to nanocarrier technology exemplify her role as an innovator in the field. Her work not only advances scientific understanding but also holds promise for future medical applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…